Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Screening and prophylaxis of cancer

Screening and prophylaxis of cancer editorial memo (2019) 12:192–193 https://doi.org/10.1007/s12254-019-00526-7 Holger Rumpold Received: 20 August 2019 / Accepted: 22 August 2019 © Springer-Verlag GmbH Austria, part of Springer Nature 2019 Cancer is the second most common cause of death specific antigen measurements for early detection of in developed countries, preceded only by heart dis- prostate cancer are key examples illustrating the po- eases. Due to demographic changes, the number of tential harm for overtreating indolent or harmless dis- cancer patients is rising and will increase to an esti- eases. mated 15 million people in the United States by 2020, However, prevention is more than only performing for example. This increase is complemented by the specific examinations in obviously healthy people. It recent progress in treatment of cancer. This has led to is much better described as the “protection of health a significant increase of cancer-related survival rates by personal and community-wide efforts,” as defined across all entities. The success in the fight against by Miller and colleagues [1]. As well as describing the cancer is further augmented by screening programs burden of disease, this also includes identification of enabling the detection of cancer in early stages, when the causes of cancer. Due to the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Screening and prophylaxis of cancer

Loading next page...
 
/lp/springer-journals/screening-and-prophylaxis-of-cancer-f78q4CWQF8

References (5)

Publisher
Springer Journals
Copyright
Copyright © 2019 by Springer-Verlag GmbH Austria, part of Springer Nature
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-019-00526-7
Publisher site
See Article on Publisher Site

Abstract

editorial memo (2019) 12:192–193 https://doi.org/10.1007/s12254-019-00526-7 Holger Rumpold Received: 20 August 2019 / Accepted: 22 August 2019 © Springer-Verlag GmbH Austria, part of Springer Nature 2019 Cancer is the second most common cause of death specific antigen measurements for early detection of in developed countries, preceded only by heart dis- prostate cancer are key examples illustrating the po- eases. Due to demographic changes, the number of tential harm for overtreating indolent or harmless dis- cancer patients is rising and will increase to an esti- eases. mated 15 million people in the United States by 2020, However, prevention is more than only performing for example. This increase is complemented by the specific examinations in obviously healthy people. It recent progress in treatment of cancer. This has led to is much better described as the “protection of health a significant increase of cancer-related survival rates by personal and community-wide efforts,” as defined across all entities. The success in the fight against by Miller and colleagues [1]. As well as describing the cancer is further augmented by screening programs burden of disease, this also includes identification of enabling the detection of cancer in early stages, when the causes of cancer. Due to the

Journal

memo - Magazine of European Medical OncologySpringer Journals

Published: Sep 26, 2019

There are no references for this article.